Compier XEVMPD

Home / Innovation / Compier XEVMPD

Gain efficiency and compliance with our XEVMPD solution for managing medicinal product submission and management

As per Article 57 of European Medicinal Agency (EMA) it is  mandatory for all marketing authorization holders (MAHs) and sponsors of clinical trial to submit product information to xEVMPD (Eudravigilance Medicinal Product Dictionary) database. Our technology platform, process accelerators and regulatory expertise enable you to Receive, Validate, Manage and Facilitate the end to end process of product submission to EU agency.

Product data management for multiple medicinal products registered in numerous different regions involves significant effort, it can be a time consuming and costly process. Our technology and solution experts help you manage the current product submission requirements and work with you to define road map for transitioning into evolving ISOs Identification of Medicinal Products (IDMP) standards.

Compier XEVMPD

Compier XEVMPD component enable you to efficiently submit and manage product registrations with the EMA and other regional authorities. Its intuitive interface allows you to browse data without requiring a detailed knowledge of the regulatory data model. Readily available dashboards and data listings enable you for better management of product registration life cycle.

Business Background

Key Product Features

  • Validates information about excipients and adjuvants and their concentrations within the finished product along with the printed product information. It also validates technical substance information for which clarifications are still pending from EMA
  • Help regulatory people maintain regulatory information and Pharmacovigilance people maintain Pharmacovigilance information, and where interested parties throughout the organization can have ‘read only’ access to both, can bring huge benefits in terms of visibility of the product portfolio, key timelines and resource planning generally
  • The solution comes with an e-submission gateway as an add-on option to enable secure and automatic e-submission via gateway. Also, it can be easily integrated with your existing e-submission gateway
  • Easily integrate with your internal and external data source systems such as product master, external data from CRO/ CMO partners
  • Our configuration and validation services assist customers in completing the configurations and validation specifications

How Do we Deliver

Compier XEVMPD is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform.

New Insights

4 Effective Strategies to Accelerate Site Selection to Activation

Introduction to the site selection process Clinical research organizations (CRO) predominantly rely on the internal networks and investigator database to support a clinical study for a drug. As the clinical sphere continues to expand at a rapid pace, there is an upsurge in demand for clinical trial sites worldwide. CROs are striving for new sites […]

Aggregate Reporting – Significance, Classification and Challenges

Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

Literature Screening – Process overview, challenges en-route and the scope for automation

Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific […]

Get in Touch with Us